İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

indivior schweiz ag - buprenorphinum, naloxonum - sublingualtabletten - buprenorphinum 2 mg ut buprenorphini hydrochloridum, naloxonum 0.5 mg ut naloxoni hydrochloridum dihydricum, lactosum monohydricum corresp. lactosum 41.87 mg, mannitolum, maydis amylum, povidonum k 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.06 mg, aromatica (zitrone und limette) cum linaloolum et citralum et e 320, acesulfamum kalicum, magnesii stearas, pro compresso. - terapia sostitutiva in caso di dipendenza da oppiacei - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

indivior schweiz ag - buprenorphinum, naloxonum - sublingualtabletten - buprenorphinum 8 mg ut buprenorphini hydrochloridum, naloxonum 2 mg ut naloxoni hydrochloridum dihydricum, lactosum monohydricum corresp. lactosum 167.5 mg, mannitolum, maydis amylum, povidonum k 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.24 mg, aromatica (zitrone und limette) cum linaloolum et citralum et e 320, acesulfamum kalicum, magnesii stearas, pro compresso. - terapia sostitutiva in caso di dipendenza da oppiacei - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pramipexolum - compresse - pramipexoli dihydrochloridum monohydricum 0.125 mg corresp. pramipexolum 0.088 mg, mannitolum, cellulosum microcristallinum, carboxymethylamylum natricum a, povidonum k 25, silica colloidalis anhydrica, magnesii stearas, natrii stearylis fumaras pro compresso corresp. natrium max. 0.184 mg. - il morbo di parkinson, trattamento sintomatico del idiopatica restless legs sindrome (rls) - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pramipexolum - compresse - pramipexoli dihydrochloridum monohydricum 0.25 mg corresp. pramipexolum 0.18 mg, mannitolum, cellulosum microcristallinum, carboxymethylamylum natricum a, povidonum k 25, silica colloidalis anhydrica, magnesii stearas, natrii stearylis fumaras pro compresso corresp. natrium max. 0.368 mg. - il morbo di parkinson, trattamento sintomatico del idiopatica restless legs sindrome (rls) - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pramipexolum - compresse - pramipexoli dihydrochloridum monohydricum 0.5 mg corresp. pramipexolum 0.35 mg, mannitolum, cellulosum microcristallinum, carboxymethylamylum natricum a, povidonum k 25, silica colloidalis anhydrica, magnesii stearas, natrii stearylis fumaras pro compresso corresp. natrium max.0.736 mg. - il morbo di parkinson, trattamento sintomatico del idiopatica restless legs sindrome (rls) - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pramipexolum - compresse - pramipexoli dihydrochloridum monohydricum 1.0 mg corresp. pramipexolum 0.7 mg, mannitolum, cellulosum microcristallinum, carboxymethylamylum natricum a, povidonum k 25, silica colloidalis anhydrica, magnesii stearas, natrii stearylis fumaras pro compresso corresp. natrium max. 0.736 mg. - il morbo di parkinson, trattamento sintomatico del idiopatica restless legs sindrome (rls) - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 0.375 mg corresp. pramipexolum 0.262 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 0.750 mg corresp. pramipexolum 0.524 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 1.500 mg corresp. pramipexolum 1.049 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

boehringer ingelheim (schweiz) gmbh - pramipexolum - retardtabletten - pramipexoli dihydrochloridum monohydricum 3.00 mg corresp. pramipexolum 2.097 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso. - morbo di parkinson - synthetika